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Summary. This review gives information about 
localization and types of MFH in man and animals such 
as mouse, rat, cat, dog, opossum, cattle, horse and birds 
[e.g. mallard (a wild duck)]. Furthermore, this paper 
reports about cell culture dealing with MFH. 
The aim of this publication is to show that MFH 
originates from a primitive mesenchymal stem cell, 
fibroblastoid cell and fibroblasts. Histiocytes are, 
according to the literature in a small amount constituents 
of MFH and are reactive cells or without any meaning. 
In our own studies using rats [strain: Chbb: THOM 
(SPF)] the characteristic storiform or cartwheel pattern 
of tumour cells were evident. The cells were elongated, 
rich in endoplasmic reticulum and possessed no or very 
few lysosomes. The cells were predominantly fibroblasts 
and fibroblastoid cells. These cells were intermingled 
with giant cells. In other species mentioned above, the 
MFH showed very similar histological features. Our own 
results and findings obtained from the literature support 
our concept that the MFH represents a primitive 
phenotype or pleomorphic sarcoma which may 
differentiate in one or more directions. Histiocytes are 
not a neoplastic component. 
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Introduction 
The human MFH, a not uncommon type of soft 
tissue sarcoma (Zagars et al., 1996), is a neoplasm of 
late adult life (Kirchner et al., 1984b; Cole et al., 1993; 
Fang et al., 1996) but often found in children too (Cole 
et al., 1993; Kodet et al., 1993; Malone, 1993; Corpron 
et al., 1996; Hari et al., 1996; Palmer et al., 1997; Shah 
et al., 1996). 
According to Burke and Virmans (1993) who 
studied MFH in great vessels (see below; next chapter), 
the mean age of adult patients suffering from MFH was, 
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e.g., 62.3 years (aorta) or 49.9 (inferior vena cava). The 
average span of lives was 23-93 years. 
MFH was first described as  a distinct type of 
sarcoma by O'Brien and Stout (1964). The tumour is 
called synonymously as malignant fibrous xanthoma or 
pleomorphous fibrous xanthoma according to Weiss and 
Enzinger (1978). Little and McCarthy (1993) designated 
this tumour as a high-grade primary bone sarcoma. 
Requena et al. (1997) emphasized that an atypical fibro- 
xanthoma was a superficial variant of pleomorphic 
MFH. 
MFH is often a consequence of therapy, mostly after 
radiotherapy or chemotherapy with doxorubicin and 
cyclophosphamide (Costa, 1994). This neoplasm is also 
induced by 4-hydroxyamino-quinoline-l-oxide (Mii et 
al., 1982), 7,12-dimethylbenz(a)anthracene (Nikitin et 
al., 1993) or by a similar agent (Sakamoto, 1986) in rats. 
Narita et al. (1997) described a family aggregation of 
soft tissue sarcomas which they designated in part as 
MFH. The authors concluded that the observed features 
closely resembled the Li-Fraumeni syndrome because 
they noted different neoplasms (liposarcoma and gastric 
carcinoma) seen at the very same time as MFH. 
MFH is  sometimes a consequence of primary 
diseases e.g. fibrous dysplasia (Ruggieri et al., 1994; 
Ohmori et al., 1996) a benign disease which often occurs 
predominantly in the area of femur, tibia and face's skull 
(monoostotic, Morbus Jaffe-Lichtenstein; the polyostotic 
variant mostly found in gir ls  is named Albright- 
syndrome). After fibrous dysplasia a fibrosarcoma or 
osteosarcoma could also be a consequence (Ruggieri et 
al., 1994). According to Little and McCarthy (1993) 
MFH is sometimes the consequence of post-radio- 
therapy, Paget's disease, osteosarcoma or giant cell 
tumour. 
The question arises as to whether the designation as 
MFH is justified. It is the aim of our review to clarify 
this. Since the publication by Leder (1967) it is well- 
known, that phagocytic cells such as histiocytes, 
macrophages but also resident phagocytes like Kupffer's 
cells of the liver originate from monocytes. Because 
malignant cells possess characteristics of stem cells the 
MFH must actually derive from monocytes. Mature 















